Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Perkinelmer (PKI)

Perkinelmer (PKI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,567,719
  • Shares Outstanding, K 126,412
  • Annual Sales, $ 3,312 M
  • Annual Income, $ 569,180 K
  • 60-Month Beta 1.10
  • Price/Sales 4.44
  • Price/Cash Flow 9.88
  • Price/Book 1.83
Trade PKI with:
  • Price/Earnings ttm 17.78
  • Earnings Per Share ttm 6.54
  • Most Recent Earnings $1.01 on 05/11/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.28 (0.24%)
  • Most Recent Dividend 0.070 on 04/20/23
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 1.20
  • Number of Estimates 5
  • High Estimate 1.26
  • Low Estimate 1.16
  • Prior Year 2.32
  • Growth Rate Est. (year over year) -48.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
114.29 +0.83%
on 05/11/23
137.09 -15.94%
on 04/17/23
-21.87 (-15.95%)
since 04/14/23
3-Month
114.29 +0.83%
on 05/11/23
139.04 -17.12%
on 04/14/23
-20.09 (-14.85%)
since 02/15/23
52-Week
113.46 +1.57%
on 10/13/22
170.00 -32.21%
on 08/01/22
-33.37 (-22.45%)
since 05/13/22

Most Recent Stories

More News
Stocks Settle Mixed as Tech Gains on Alphabet and Lower Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 5,306.04 (+0.02%)
SPY : 529.81 (+0.07%)
$DOWI : 38,852.86 (-0.55%)
DIA : 388.60 (-0.52%)
$IUXX : 18,869.44 (+0.32%)
QQQ : 459.68 (+0.38%)
PACW : 7.54 (-2.71%)
CMA : 50.47 (-0.59%)
TFC : 37.75 (-1.69%)
ZION : 42.52 (-1.32%)
RF : 19.06 (-0.31%)
HBAN : 13.66 (-0.58%)
Stocks Weighed Down by Weakness in Disney and Regional Bank Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.21%....

$SPX : 5,306.04 (+0.02%)
SPY : 529.81 (+0.07%)
$DOWI : 38,852.86 (-0.55%)
DIA : 388.60 (-0.52%)
$IUXX : 18,869.44 (+0.32%)
QQQ : 459.68 (+0.38%)
PACW : 7.54 (-2.71%)
CMA : 50.47 (-0.59%)
FITB : 36.68 (-1.53%)
TFC : 37.75 (-1.69%)
ZION : 42.52 (-1.32%)
DIS : 102.44 (+0.67%)
Revvity's (PKI) Q1 Earnings Top, '23 View Below Expectations

Revvity's (PKI) first-quarter results reflect the impact of transition following divestment of AES business. While earnings outpace estimates, sales miss the same.

CAH : 94.75 (-1.70%)
ABC : 179.98 (-0.23%)
PKI : 115.24 (-0.91%)
MMSI : 81.50 (-0.51%)
PerkinElmer (PKI) Q1 Earnings Surpass Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of 2.02% and 1.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PKI : 115.24 (-0.91%)
MDXH : 2.77 (+1.47%)
PerkinElmer: Q1 Earnings Snapshot

PerkinElmer: Q1 Earnings Snapshot

PKI : 115.24 (-0.91%)
Is a Surprise Coming for Revvity (PKI) This Earnings Season?

Revvity (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

PKI : 115.24 (-0.91%)
Waters (WAT) Lags Q1 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of -4.23% and 1.55%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

WAT : 331.84 (-1.37%)
PKI : 115.24 (-0.91%)
Revvity (PKI) to Report Q1 Earnings: Is a Beat in the Cards?

Revvity's (PKI) first-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.

PKI : 115.24 (-0.91%)
IKNA : 1.3300 (unch)
SRZN : 10.43 (-0.18%)
IVVD : 1.7600 (-8.81%)
McKesson (MCK) to Report Q4 Earnings: Is a Beat in Store?

McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.

MCK : 549.26 (-2.05%)
PKI : 115.24 (-0.91%)
APTX : 0.0960 (+3.11%)
BRBR : 57.76 (-1.03%)
PerkinElmer (PKI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

PerkinElmer (PKI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PKI : 115.24 (-0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software,...

See More

Key Turning Points

3rd Resistance Point 119.28
2nd Resistance Point 118.25
1st Resistance Point 116.74
Last Price 115.24
1st Support Level 114.20
2nd Support Level 113.17
3rd Support Level 111.66

See More

52-Week High 170.00
Fibonacci 61.8% 148.40
Fibonacci 50% 141.73
Fibonacci 38.2% 135.06
Last Price 115.24
52-Week Low 113.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar